The Centers for Medicare & Medicaid Services (CMS) has contracted with Abt Associates and RTI International to develop a drug regimen review measure, for the medication reconciliation domain, in alignment with the Improving Post-Acute Care Transformation Act of 2014 (known as the IMPACT Act). As part of its measure development process, CMS asks contractors to convene groups of stakeholders and experts who contribute direction and thoughtful input to the measure contractor during measure development and maintenance.
We are writing to notify you that additional details about this project and the nomination materials are available at the following website: https://www.cms.gov/Medicare/
Quality-Initiatives-Patient- Assessment-Instruments/MMS/ Downloads/IMPACT-Act-of-2014- Cross-Setting-Quality-Measure- Drug-Regimen-Review.zip
If you wish to nominate yourself or other individuals for consideration, please email materials to: Nicole_Keane@abtassoc.com by the closing date June 30th, 2015.